APA (7th ed.) Citation

Zhang, W., Qiao, X., Liang, X., Li, Y., Yang, R., & Wang, Z. (2021). Efficacy and safety of short-term 1–3 months versus standard 12 months dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: A meta-analysis of randomized clinical trials. Platelets, 32(5), 582. https://doi.org/10.1080/09537104.2020.1786039

Chicago Style (17th ed.) Citation

Zhang, Wen-Jiao, Xuan Qiao, Xi-Ying Liang, Yan Li, Rong-Rong Yang, and Zhi-Lu Wang. "Efficacy and Safety of Short-term 1–3 Months Versus Standard 12 Months Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention: A Meta-analysis of Randomized Clinical Trials." Platelets 32, no. 5 (2021): 582. https://doi.org/10.1080/09537104.2020.1786039.

MLA (9th ed.) Citation

Zhang, Wen-Jiao, et al. "Efficacy and Safety of Short-term 1–3 Months Versus Standard 12 Months Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention: A Meta-analysis of Randomized Clinical Trials." Platelets, vol. 32, no. 5, 2021, p. 582, https://doi.org/10.1080/09537104.2020.1786039.